MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$4,208,134
Free Cash flow
-$1,640,277
Unit: Dollar
Positive Cash Flow Breakdown
Net proceeds from issuance of co...
Stock-based compensation
Grants receivable
Others
Negative Cash Flow Breakdown
Net loss
Change in fair value of derivati...
Non-cash lease expense
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-2,878,614
-2,370,247
-2,655,036
-2,286,991
Amortization of deferred grant reimbursement
-11,991
-11,992
-12,700
-13,055
Depreciation of property and equipment
76,949
74,147
73,599
71,603
Change in fair value of derivative instruments
172,859
-
-
-
Non-cash lease expense
-28,751
20,897
15,503
23,235
Stock-based compensation
1,218,939
501,098
677,866
425,708
Grants receivable
-101,607
-214,496
214,716
45,236
Due from related party
-18,616
-
-
-
Prepaid expenses and other current assets
-46,318
-40,341
184,166
-88,699
Tax receivable
-
-
-621
105,826
Accounts payable and accrued expenses
40,146
-1,257
330,984
-26,276
Due to related party
-13,406
8,076
-5,755
11,431
Net cash (used in) operating activities
-1,640,278
-1,524,441
-1,973,800
-1,856,708
Deferred grant reimbursement
-
-
-2
2
Purchases of property and equipment
-1
57,604
74,988
13,310
Net cash provided by (used in) investing activities
1
-57,604
-74,990
-13,308
Net proceeds from issuance of common stock and warrants
5,861,147
-
-
-
Payments on finance lease obligations
12,736
12,736
10,554
17,155
Net cash provided by financing activities
5,848,411
-12,736
-10,554
-17,155
Net increase (decrease) in cash, cash equivalents
4,208,134
-1,594,781
-2,059,344
-1,887,171
Cash and cash equivalents - beginning of period
1,444,562
3,039,343
5,098,687
9,719,310
Cash and cash equivalents - end of period
5,652,696
1,444,562
3,039,343
5,098,687
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net proceeds from
issuance of common stock...
$5,861,147
Purchases of property and
equipment
-$1
(-100.00%↓ Y/Y)
Net cash provided by
financing activities
$5,848,411
Net cash provided by
(used in) investing...
$1
(100.00%↑ Y/Y)
Canceled cashflow
$12,736
Net increase
(decrease) in cash, cash...
$4,208,134
(253.95%↑ Y/Y)
Canceled cashflow
$1,640,278
Payments on finance lease
obligations
$12,736
Stock-based compensation
$1,218,939
(37.81%↑ Y/Y)
Grants receivable
-$101,607
(78.83%↑ Y/Y)
Depreciation of property and
equipment
$76,949
(-46.10%↓ Y/Y)
Prepaid expenses and
other current assets
-$46,318
(39.35%↑ Y/Y)
Accounts payable and
accrued expenses
$40,146
(529.54%↑ Y/Y)
Net cash (used in)
operating activities
-$1,640,278
(38.60%↑ Y/Y)
Canceled cashflow
$1,483,959
Net loss
-$2,878,614
(31.73%↑ Y/Y)
Change in fair value of
derivative instruments
$172,859
Non-cash lease expense
-$28,751
(-296.53%↓ Y/Y)
Due from related
party
-$18,616
Due to related party
-$13,406
(58.38%↑ Y/Y)
Amortization of deferred
grant reimbursement
-$11,991
(55.85%↑ Y/Y)
Buy us a coffee
EXOZYMES INC. (EXOZ)
EXOZYMES INC. (EXOZ)